Mitsuo Katano
- Oncology top 1%
- Cancer-related Molecular Pathways 11
- Cancer Cells and Metastasis 11
- Cancer Research top 2%
- NF-κB Signaling Pathways 12
- Immunology top 2%
- Immunotherapy and Immune Responses 33
- Immune Cell Function and Interaction 26
- T-cell and B-cell Immunology 18
- Molecular Biology top 2%
- Hedgehog Signaling Pathway Studies 34
- Epigenetics and DNA Methylation 24
- Co-authors
- Masao TanakaTakashi MorisakiHideya OnishiMasafumi NakamuraHisashi MatsunagaMotomichi TorisuMakoto KuboJunji Wada
- Cited by
- OncologyCancer ResearchImmunology
- Journals
- Cancer Immunology Immunotherapy (12 papers)Cancer Science (10 papers)Cancer Letters (8 papers)
- Partner nations
- JapanUnited StatesGermany
In The Last Decade
Mitsuo Katano
156 papers receiving 5.3k citations
Peers
Comparison fields: 5 of 129
- Oncology 2.1k
- Cancer Research 1.0k
- Immunology 1.3k
- Molecular Biology 2.9k
- Pathology and Forensic Medicine 361
Countries citing papers authored by Mitsuo Katano
This map shows the geographic impact of Mitsuo Katano's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mitsuo Katano with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mitsuo Katano more than expected).
Fields of papers citing papers by Mitsuo Katano
This network shows the impact of papers produced by Mitsuo Katano. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mitsuo Katano. The network helps show where Mitsuo Katano may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Mitsuo Katano, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2016 | 26 | |
| 2 | 2013 | 45 | |
| 3 | 2013 | 25 | |
| 4 | A new method for rapid cytotoxic T-lymphocyte induction using a multiple cytokine cocktail. | 2012 | 4 |
| 5 | 2012 | 39 | |
| 6 | 2011 | 81 | |
| 7 | 2011 | 79 | |
| 8 | Long-term outcome of immunotherapy for patients with refractory pancreatic cancer. | 2009 | 24 |
| 9 | 2009 | 146 | |
| 10 | 2008 | 60 | |
| 11 | Evaluation of a dysfunctional and short-lived subset of monocyte-derived dendritic cells from cancer patients. | 2005 | 4 |
| 12 | Purification, characterization and biological significance of tumor-derived exosomes. | 2005 | 204 |
| 13 | Combination of adoptive immunotherapy with Herceptin for patients with HER2-expressing breast cancer. | 2004 | 25 |
| 14 | 2004 | 25 | |
| 15 | 2001 | 2 | |
| 16 | 1997 | 5 | |
| 17 | 1996 | 30 | |
| 18 | 1995 | 23 | |
| 19 | 1993 | 1 | |
| 20 | 1993 | 2 |
About Mitsuo Katano
Mitsuo Katano is a scholar working on Immunology, Oncology, Cancer Research, Molecular Biology and Immunology and Allergy, having authored 157 papers that have together received 5.5k indexed citations. Recurring topics across this work include Hedgehog Signaling Pathway Studies (34 papers), Immunotherapy and Immune Responses (33 papers), Immune Cell Function and Interaction (26 papers), Epigenetics and DNA Methylation (24 papers), T-cell and B-cell Immunology (18 papers), NF-κB Signaling Pathways (12 papers), Cancer-related Molecular Pathways (11 papers) and Cancer Cells and Metastasis (11 papers). The work is most often cited by research in Oncology (2.1k citations), Cancer Research (1.0k citations), Immunology (1.3k citations), Molecular Biology (2.9k citations) and Pathology and Forensic Medicine (361 citations). Mitsuo Katano has collaborated with scholars based in Japan, United States and Germany. Frequent co-authors include Masao Tanaka, Takashi Morisaki, Hideya Onishi, Masafumi Nakamura, Hisashi Matsunaga, Motomichi Torisu, Makoto Kubo, Junji Wada, Akio Yamasaki and Kenichiro Koga. Their work appears in journals such as Cancer Immunology Immunotherapy, Cancer Science, Cancer Letters, Journal of Surgical Oncology and Chemical and Pharmaceutical Bulletin.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.